TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer

Colorectal cancer (CRC) remains a leading cause of cancer‐related deaths worldwide. Although treatment strategies for solid tumours have been revolutionized by immunotherapy, only a small subset of CRC patients benefit. Using two‐independent cohorts, we found the common frequently mutated genes TTN...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Wang, Libo, Guo, Chunguang, Liu, Long, Jiao, Dechao, Sun, Zhenqiang, Wu, Kunpeng, Zhao, Yanan, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034451/
https://www.ncbi.nlm.nih.gov/pubmed/33624434
http://dx.doi.org/10.1111/jcmm.16393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034451/
https://www.ncbi.nlm.nih.gov/pubmed/33624434
http://dx.doi.org/10.1111/jcmm.16393

Ejemplares similares